Astorg Partners and Goldman Sachs Merchant Banking Division acquired HRA Pharma, an independent specialty pharmaceuticals company active in the field of women's health and endocrinology, from its founders and The Riverside Company. Financial terms were not disclosed. Erin Gainer, CEO of HRA Pharma said: "This deal opens an exciting new chapter for the company. It will allow us to deliver immediate value to our historical shareholders, while continuing to innovate, invest in strategic growth initiatives and extend the company's operational reach. In the years to come we aspire to enter the US market and to continue to deliver new and best-in-class medicines to our patients, healthcare providers and partners. We closed out 2015 with record sales growth. With the backing of Astorg and Goldman Sachs Merchant Banking Division, two world-class investors with outstanding reputations and networks, we have the resources and the ambition to take the business to a new level."